Ligand · 2IF
2IF · ~{N}1,~{N}3-bis[4-[[(4~{R})-4-[[4-[[3,5-bis(bromanyl) phenyl]methoxy]phenyl]sulfonylamino]-5-(oxidanylamino)-5-oxidanylidene-pentyl]amino]-4-oxidanylidene-butyl]benzene-1,3-dicarboxamide
2IF, ~{N}1,~{N}3-bis[4-[[(4~{R})-4-[[4-[[3,5-bis(bromanyl) phenyl]methoxy]phenyl]sulfonylamino]-5-(oxidanylamino)-5-oxidanylidene-pentyl]amino]-4-oxidanylidene-butyl]benzene-1,3-dicarboxamide (C52 H58 Br4 N8 O14 S2, 1402.8 g/mol), in the…
- Component
- 2IF
- Formula
- C52 H58 Br4 N8 O14 S2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
2IF in 2 structures; the first of them:
- 7OVY · Crystal structure of a dimeric based inhibitor JG34 in complex with the MMP-12 catalytic… · 2IF A306 · binds GLY179, ILE180, LEU181, ALA182, HIS183, LEU214, THR215, HIS218 and 14 more
- 7OVY · Crystal structure of a dimeric based inhibitor JG34 in complex with the mmp-12 catalytic… · 2IF A306 · binds GLY179, ILE180, LEU181, ALA182, LEU214, HIS218, GLU219, HIS222 and 9 more
Residues it binds most
HIS 2, ALA 2, LEU 2, PRO 2, LYS 2, PHE 2, THR 2, VAL 2, GLU 2, GLY 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.